Trademark Overview
On Friday, December 8, 2023, a trademark application was filed for PRISMDIRECT with the United States Patent and Trademark Office. The USPTO has given the PRISMDIRECT trademark a serial number of 98305240. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 15, 2024. This trademark is owned by Scipher Medicine Corporation. The PRISMDIRECT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing collected and analyzed medical information in the field of autoimmune diseases and treatment information for complex diseases and disorders for diagnostic and treatment purposes; providing medical data and information to pharmaceutical companies and healthcare providers; medical screening information services featuring alerts to pharmaceutical companies related to healthcare providers ordering medical diagnostic testing for patients; providing healthcare information and medical diagnostic services in the field of precision medicine, personalized medicine, and autoimmune disease; providing information in the fields of autoimmune diseases and pharmaceuticals
Data mining services in the field of precision medicine, personalized medicine and genomic sequencing; providing an AI-based data analytics platform in the field of precision medicine, personalized medicine, genomic sequencing and autoimmune diseases; software as a service (SAAS) featuring AI-based software for patient analytics in the field of precision medicine, personalized medicine, and autoimmune diseases; platform as a service (PAAS) featuring AI-based software for data analytics related to non-TNFi responder patients; platform as a service (PAAS) featuring AI-based software for use in providing data analytics and data insights; technology driven research, consultation, and platform services, namely consulting and providing PAAS featuring AI-based software in the field of precision medicine, personalized medicine and autoimmune diseases; diagnostic laboratory services in the field of precision medicine; scientific research in the field of disease modeling and precision medicine